Tudor Investment Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tudor Investment Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,725	Closed	-$5.05M	–	3969
2025 Q4	$5.05M	Buy	+29,725	New	+$4.56M	0.01%	1145
2025 Q2	–	Sell	-8,749	Closed	-$1.09M	–	3500
2025 Q1	$1.09M	Buy	+8,749	New	+$1.14M	﹤0.01%	1761
2024 Q2	–	Sell	-25,702	Closed	-$3.1M	–	2549
2024 Q1	$3.1M	Sell	25,702 -7,256	-22%	-$889K	0.02%	814
2023 Q4	$4.05M	Buy	32,958 +24,814	+305%	+$3.1M	0.03%	734
2023 Q3	$1.05M	Sell	8,144 -9,909	-55%	-$1.32M	0.01%	1271
2023 Q2	$2.24M	Buy	+18,053	New	+$2.43M	0.03%	839
2023 Q1	–	Sell	-23,795	Closed	-$3.79M	–	2682
2022 Q4	$3.79M	Sell	23,795 -1,244	-5%	-$182K	0.08%	338
2022 Q3	$3.34M	Sell	25,039 -5,529	-18%	-$841K	0.07%	343
2022 Q2	$4.77M	Buy	30,568 +23,092	+309%	+$3.55M	0.13%	189
2022 Q1	$1.16M	Buy	7,476 +3,778	+102%	+$548K	0.03%	823
2021 Q4	$471K	Sell	3,698 -7,426	-67%	-$976K	0.01%	1523
2021 Q3	$1.45M	Buy	+11,124	New	+$1.68M	0.02%	919
2021 Q2	–	Sell	-2,561	Closed	-$421K	–	1750
2021 Q1	$421K	Buy	+2,561	New	+$421K	0.01%	1195
2020 Q3	–	Sell	-2,654	Closed	-$293K	–	1421
2020 Q2	$293K	Sell	2,654 -33,198	-93%	-$3.67M	0.01%	892
2020 Q1	$3.58M	Sell	35,852 -13,292	-27%	-$1.72M	0.32%	35
2019 Q4	$7.34M	Buy	+49,144	New	+$6.69M	0.33%	48
2019 Q3	–	Sell	-19,380	Closed	-$2.76M	–	1214
2019 Q2	$2.76M	Sell	19,380 -77	-0.4%	-$10.3K	0.08%	223
2019 Q1	$2.78M	Sell	19,457 -2,514	-11%	-$328K	0.12%	194
2018 Q4	$2.72M	Buy	+21,971	New	+$3.26M	0.05%	130
2018 Q3	–	Sell	-1,474	Closed	-$254K	–	1165
2018 Q2	$254K	Buy	+1,474	New	+$241K	0.01%	865
2018 Q1	–	Sell	-14,313	Closed	-$1.93M	–	1104
2017 Q4	$1.93M	Buy	+14,313	New	+$1.99M	0.05%	180
2017 Q3	–	Sell	-4,664	Closed	-$725K	–	1173
2017 Q2	$725K	Buy	4,664 +2,278	+95%	+$348K	0.02%	441
2017 Q1	$346K	Sell	2,386 -5,723	-71%	-$745K	0.01%	914
2016 Q4	$884K	Sell	8,109 -10,048	-55%	-$1.12M	0.02%	428
2016 Q3	$2.21M	Sell	18,157 -8,392	-32%	-$1.13M	0.05%	188
2016 Q2	$3.75M	Buy	26,549 +12,997	+96%	+$1.92M	0.08%	129
2016 Q1	$1.77M	Buy	13,552 +6,764	+100%	+$842K	0.05%	294
2015 Q4	$954K	Buy	6,788 +1,257	+23%	+$174K	0.03%	481
2015 Q3	$735K	Buy	+5,531	New	+$952K	0.02%	541
2015 Q1	–	Sell	-1,400	Closed	-$229K	–	1528
2014 Q4	$229K	Sell	1,400 -200	-13%	-$33.2K	0.01%	1205
2014 Q3	$257K	Buy	1,600 +200	+14%	+$30.7K	0.01%	1091
2014 Q2	$206K	Sell	1,400 -2,700	-66%	-$374K	0.01%	1030
2014 Q1	$569K	Buy	4,100 +1,163	+40%	+$175K	0.02%	455
2013 Q4	$372K	Sell	2,937 -2,563	-47%	-$265K	0.02%	760
2013 Q3	$506K	Sell	5,500 -2,700	-33%	-$218K	0.02%	338
2013 Q2	$564K	Buy	+8,200	New	+$501K	0.04%	276

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tudor Investment Corp's JAZZ Position: Q1 2026 in Review

Tudor Investment Corp sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 29,725 shares — an estimated $5.05M sold.

Tudor Investment Corp first reported a position in JAZZ in Q2 2013 and held it in 36 quarters. The position peaked at $7.34M in Q4 2019. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Tudor Investment Corp reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Tudor Investment Corp sold 29,725 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.05M.
Tudor Investment Corp first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 36 quarters.
Tudor Investment Corp's Jazz Pharmaceuticals position peaked at $7.34M in Q4 2019.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.